ETC 6 Meridian Low Beta Equity ETF

Dollar General CIO Sells Company Common Stock

Jan Malcolm of Combined Therapeutics Reports Sale of Common Stock

CEO of United Therapeutics Disposes of Company's Common Stock

CACI International Director William L. Jews Sells Company Common Stock

Bayesian Capital Management Significantly Increases Holdings in Dollar General

HSBC Holdings PLCCuts Holding in InterDigital Inc

Insiders of United Therapeutics sold $3,833,374 worth of shares

Nilda Mesa Sold Shares of Combined Therapeutics

Dollar Tree's Chief People Officer Sells Common Stock

Dollar General Raises Full-Year Outlook Driving Stock Price Up

CFO of United Therapeutics Sells Common Stock

CEO of United Therapeutics Disposes of Company Common Stock

Dollar General Pays $1.55 Million Pricing Settlement in Pennsylvania

CEO Martin A Rothblatt of United Therapeutics Disposes of Company Common Stock

InterDigital Inc. CTO Reports Sale of Company Common Stock

Dollar General Plans to Open 450 New Stores in 2026 and Reports Near 5% Net Sales Growth

Dalton Reports Earnings Per Share Above Expectations

Takeda and Protagonist Announce 52-Week Data for Rusfertide and Plan to Seek Regulatory Approval

Chief Executive Officer of Combined Therapeutics Disposes of Company Common Stock

Dollar General's stock rises after analysts raise their price targets

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

UTHR

Malcolm Jan Director of United Therapeutics Corp [UTHR] filed a Form 4 on December 12, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/11/25TransactionPlanned Sale(1) Shares50Price$482.98Value$24,149Ending Holdings: 470 - Direct(1) Executed pursuant to a prearranged trading plan (10b5-1).For a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Reuters

United Therap

Dir Malcolm Sells 50 ($24.1K) Of United Therapeutics Corp [UTHR]

Martine A. Rothblatt, Chairman of United Therapeutics Corp, sold 8,000 shares worth $3.9M, as disclosed in a Form 4 filed with the SEC. The transaction was executed under a prearranged trading plan (10b5-1). Ending holdings are 639,489 shares. The Washington Service offers insider trading analysis and data services.

Chmn Rothblatt Sells 8,000 ($3.9M) Of United Therapeutics Corp [UTHR]

Jan Malcolm, Director of United Therapeutics Corporation, reported the sale of common shares. The full filing is available via EDGAR, the U.S. SEC's system. This information is for informational purposes only and not financial advice.

United Therapeutics Director Jan Malcolm Reports Sale of Common Shares

Martine A. Rothblatt, CEO of United Therapeutics, reported the disposal of common shares of the company. The filing is available via EDGAR, the SEC's system. This AI-generated news is for informational purposes and not financial advice.

United Therapeutics CEO Martine Rothblatt Reports Disposal of Common Shares

CACI

William L. Jews, Director of CACI International Inc., reported the sale of common shares of the company. The information was published via EDGAR by the U.S. Securities and Exchange Commission on December 12, 2025. This news brief is generated by Public Technologies using AI and is for informational purposes only.

Caci

Director William L. Jews Reports Sale of CACI International Inc. Common Shares

IDCC

InterDigital, a research and development firm in Wilmington, Delaware, has seen its stock surge 87% this year due to its portfolio of 38,000 patents in cellular wireless technology, video streaming, and AI processing. The company ranks first on Forbes' 2025 list of America's Most Successful Mid-Cap Companies. Another top performer is Nextpower, a solar tracker company, which ranks fifth on the list with its stock up 140% in the past year.

Forbes

Nextpower

InterDigital Comm

America’s Most Successful Mid Caps: Goldilocks Stocks Thriving In A Difficult Market

Zacks Research increased their FY2026 earnings per share estimates for Dycom Industries to $10.56, up from $9.88, and issued a 'Strong-Buy' rating. Dycom Industries reported Q3 earnings of $3.63 per share, beating estimates. Several other analysts also raised their price targets for the company. Dycom Industries' stock has a consensus 'Buy' rating and an average target price of $371.25.

Market Beat

Dycom Industries

Equities Analysts Set Expectations for DY FY2026 Earnings

00005

HSBC

HSBC Holdings PLC significantly reduced its stake in InterDigital, Inc. by 94.3% in Q2, selling 56,691 shares. InterDigital's stock opened at $359.88, with a market cap of $9.27 billion. Analysts have mixed ratings, with a consensus 'Buy' and an average price target of $416.67. InterDigital reported strong earnings, beating estimates, and announced a quarterly dividend of $0.70 per share.

- HSBC Holdings PLC reduced its stake in InterDigital, Inc. by 94.3%, holding 3,409 shares after selling 56,691 shares in Q2.  
- Other institutional investors, including Cetera Investment Advisers and LPL Financial LLC, increased their positions in InterDigital during the same period.  
- InterDigital reported a quarterly EPS of $1.93, exceeding estimates, and announced a dividend of $0.70 per share, with a current market cap of $9.27 billion.

HSBC HOLDINGS

InterDigital, Inc. $IDCC Shares Sold by Hsbc Holdings PLC

United Therapeutics Insider Sold Shares Worth $3,833,374, According to a Recent SEC Filing

marketscreener

United Therapeutics Insider Sold Shares Worth $3,833,374, According to a Recent SEC Filing

Nilda Mesa, Director at United Therapeutics Corporation, reported the sale of common shares of the company. The information was published via EDGAR by the U.S. SEC on December 10, 2025. This brief was generated by Public Technologies using AI and is for informational purposes only.

United Therapeutics Director Nilda Mesa Reports Sale of Common Shares

Martine A. Rothblatt, Chairman of United Therapeutics Corp, filed a Form 144 with the SEC to sell 4,000 shares on December 10, 2025, through TD Securities. This sale is part of a prearranged trading plan (10b5-1). Filing Form 144 is required before selling restricted stock, allowing the sale within 90 days of filing.

Chmn Rothblatt Files To Sell 4,000 Of United Therapeutics Corp [UTHR]

William L. Jews, Director of CACI International Inc, filed a Form 144 with the SEC to sell 3,000 restricted shares on December 10, 2025, through Merrill Lynch & Co Inc. Form 144 is required for selling restricted stock, allowing sales within 90 days of filing. The Washington Service offers insider trading analysis and data services.

Dir Jews Files To Sell 3,000 Of CACI International Inc [CACI]

Kritzmacher John A Director of InterDigital Inc [IDCC] filed a Form 4 on December 10, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/9/25TransactionPlanned Sale(1) Shares1,250Price$357.37Value$446,713Ending Holdings: 17,065 - Direct(1) Executed pursuant to a prearranged trading plan (10b5-1).For a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Dir Kritzmacher Sells 1,250 ($446.7K) Of InterDigital Inc [IDCC]

John A. Kritzmacher, Director of InterDigital Inc., reported the sale of common shares. The information was published via EDGAR by InterDigital Inc. on December 10, 2025. This brief is AI-generated by Public Technologies and is not financial advice.

Director John A. Kritzmacher Reports Sale of InterDigital Inc. Common Shares

United Therapeutics Insider Sold Shares Worth $10,050,597, According to a Recent SEC Filing